Virtu Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,645
| Closed | -$336K | – | 1587 |
|
|
2022
Q1 | $336K | Buy |
+20,645
| New | +$336K | 0.02% | 537 |
|
|
2021
Q3 | – | Sell |
-34,159
| Closed | -$540K | – | 1509 |
|
|
2021
Q2 | $540K | Buy |
+34,159
| New | +$540K | 0.05% | 433 |
|
|
2020
Q3 | – | Sell |
-23,568
| Closed | -$112K | – | 1063 |
|
|
2020
Q2 | $112K | Buy |
+23,568
| New | +$112K | 0.01% | 853 |
|
|
2019
Q4 | $269K | Buy |
77,838
+60,978
| +362% | +$211K | 0.03% | 747 |
|
|
2019
Q3 | $48K | Buy |
+16,860
| New | +$48K | ﹤0.01% | 1199 |
|
|
2018
Q2 | – | Sell |
-11,374
| Closed | -$54K | – | 1977 |
|
|
2018
Q1 | $54K | Buy |
+11,374
| New | +$54K | ﹤0.01% | 1696 |
|